Frequent Loss of Heterozygosity on Chromosome 9 in Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus

Cancer Research

Volumn 54, Issue 23, 1994, Pages 6094-6096

  Cottrell, John ^a   Yin, Jing ^a   Zhou, Xiaoling ^a   Suzuki, Hiroyuki ^a   Jiang, Hai Yan ^a   Rhyu, Mun Gan ^a   Abraham, John M ^a   Meltzer, Stephen J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; CARCINOGENESIS; CHROMOSOME 9P; ESOPHAGUS CARCINOMA; GENE LOCUS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; ESOPHAGEAL NEOPLASMS; HUMANS;

EID: 0028081164     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Franceschi, S. Talamini, R. Barra, S. Baron, A.E. Negri, E. Bidoli, E. Serraino, D. and La Vecchia, C. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in Northern Italy. Cancer Res. 50: 6502-6507, 1990.
2. Hamilton, S.R. Smith, R.L. and Cameron, J.L. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum. Pathol. 19: 942-948, 1988.
3. Hamilton, S.R. Pathogenesis of columnar cell-lined (Barrett's) esophagus. In: S. Spechler and R.K. Goyal (eds.), Barrett's Esophagus: Pathophysiology and Diagnosis, and Management, pp. 29-37. New York: Elsevier Science, 1985.
4. Reid, B.J. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol. Clin. North Am. 20: 817-834, 1991.
5. Meltzer, S.J. Yin, J. Huang, Y. McDaniel, T.K. Newkirk, C. Iseri, O. Vogelstein, B. and Resau, J.H. Reduction to homozygosity including p. 3 in esophageal cancers demonstrated by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 88: 4976-4980, 1990.
6. Huang, Y. Boynton, R.F. Blount, P.L. Silverstein, R.L. Yin, J. Tong, Y. McDaniel, T.K. Newkirk, C. Resau, J.H. Sridhara, R. Reid, B.J. and Meltzer, S.J. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res. 52: 6525-6530, 1992.
7. Boynton, R.F. Blount, P.L. Yin, J. Brown, V.L. Huang, Y. Tong, Y. McDaniel, T. Newkirk, C. Resau, J.H. Raskind, W.H. Haggitt, R.C. Reid, B.J. and Meltzer, S.J. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc. Natl. Acad. Sci. USA, 89: 3385-3388, 1992.
8. Blount, P.L. Meltzer, S.J. Yin, J. Huang, Y. Krasna, M.J. and Reid, B.J. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc. Natl. Acad. Sci. USA, 90: 3221-3225, 1993.
9. Meltzer, S.J. Yin, J. Manin, B. Rhyu, M.G. Cottrell, J. Hudson, E. Redd, J.L. Krasna, M.J. Abraham, J.M. and Reid, B.J. Microsatellite instablitiy occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res. 54: 3379-3382, 1994.
10. Lu, S.H. Hsieh, L.L. Luo, F.C. and Weinstein, I.B. Amplification of the EGF receptor and C-MYC genes in human esophageal cancers. Int. J. Cancer, 42: 502-505, 1988.
11. Jiang, W. Kahn, S.M. Tomita, N. Zhang, Y.J. Lu, S.H. and Weinstein, I.B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 52: 2980-2983, 1992.
12. Victor, T. du Toit, R.D. Jordaan, A.M. Bester, A.J. and van Helden, P.D. No evidence for point mutations in codons 12, 13, 61 of the ras gene in a high-incidence area for esophageal and gastric cancers. Cancer Res. 50: 4911-4914, 1990.
13. Meltzer, S.J. Mane, S.M. Wood, P.K. Resau, J.H. Newkirk, C. Terzakis, J.A. Korelitz, B.I. Weinstein, W.M. and Needleman, S.W. Activation of c-Ki-ras in gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res. 50: 3627-3630, 1990.
14. Diaz, M.O. Rubin, C.M. Harden, A. Ziemin, S. LeBeau, R.A. and Rowley, J.D. Deletions of interferon genes in acute lymphoblastic leukemia. N. Engl. J. Med. 322: 77-82, 1990.
15. Keen, A.J. and Knowles, M.A. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene, 9: 2083-2088, 1994.
16. Ruppert, J.M. Tokino, K. and Sidransky, D. Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res. 53: 5093-5095, 1993.
17. Cairns, P. Shaw, M.E. and Knowles, M.A. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res. 53: 1230-1232, 1993.
18. Cairns, P. Shaw, M.E. and Knowles, M.A. Initiation of bladder cancer may involve deletion of a tumor suppressor gene on chromosome 9. Oncogene, 8: 1083-1085, 1993.
19. Spruck, C.H. III, Ohneseit, P.F. Gonzalez, M. Esrig, D. Miyai, N. Tsai, Y.C. Lerner, S.P. Schmutte, C. Yang, A.S. Cote, R. Debeau, L. Nichols, P.W. Hermann, G.G. Steven, K. Horn, T. Skinner, D.G. and Jones, P.A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res. 54: 784-788, 1994.
20. Devlin, J. Keen, A.J. and Knowles, M.A. Homozygous deletion mapping at 9p. 1 in bladder carcinoma defines a critical region within 2 cM of IFNA. Oncogene, 9: 2757-2760, 1994.
21. Orlow, I. Lianes, P. Lacombe, L. Dalbagni, G. Reuter, V.E. and Cordon-Cardo, C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res. 54: 2848-2851, 1994.
22. Cairns, P. Tokino, K. Eby, Y. and Sidransky, D. Homozygous deletions of 9p. 1 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res. 54: 1422-1424, 1994.
23. James, C.D. Collins, V.P. Allalinis-Turner, M.J. and Days, R.S. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage map. Cancer Res. 53: 3674-3676, 1993.
24. Cheng, J.Q. Jhanawar, S.C. Lu, Y.Y. and Testa, J.R. Homozygous deletions within 9p. 1-22 identify a small and critical region of chromosome loss in human malignant mesotheliomas. Cancer Res. 53: 4761-4763, 1993.
25. Walker, G.J. Palmer, J.M. Walters, M.K. Nancarrow, D.J. Parsons, P.G. and Hayward, N.K. Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions. Oncogene, 9: 819-824, 1994.
26. Holland, E.A. Beaton, S.C. Edwards, B.G. Kefford, R.F. and Mann, G.J. Loss of heterozygosity and homozygous deletions on 9p. 1-22 in melanoma. Oncogene, 9: 1361-1365, 1994.
27. Isshiki, K. Seng, B.A. Elder, D.E. Guerry, D. and Linnenbach, A.J. Chromosome 9 deletion in sporadic and familial melanomas in vivo. Oncogene, 9: 1649-1653, 1994.
28. Weaver-Feldhaus, J. Gruis, N.A. Neuhausen, S. Le Paslier, D. Stockert, E. Skolnick, M.H. and Kamb, A. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl. Acad. Sci. USA, 91: 7563-7567, 1994.
29. Fountain, J.W. Karayiorgou, M. Ernstoff, M.S. Kirkwood, J.M. Vlouk, D.R. Titus-Ernstoff, L. Bouchard, B. Vijaysasaradhi, S. Houghton, A.M. Lahti, J. Housman, D.E. and Dracopoli, N.C. Homozygous deletions within human chromosome band 9p. 1 in melanoma. Proc. Natl. Acad. Sci. USA, 89: 10557-10561, 1992.
30. Coleman, A. Fountain, J.W. Nobori, T. Olopade, O.I. Robertson, G. Housman, D.E. and Lugo, T.G. Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer and leukemia. Cancer Res. 54: 344-348, 1994.
31. van der Riet, P. Nawroz, H. Hrubran, R.H. Corio, R. Tokino, K. Koch, W. and Sidransky, D. Frequent loss of chromosome 9p. 1-22 early in head and neck cancer progression. Cancer Res. 54: 1156-1158, 1994.
32. Huang, D.P. Lo, K.W. van Hasselt, C.A. Woo, J.K.S. Choi, P.H.K. Leung, S.F. Cheung, S.T. Cairns, P. Sidransky, D. and Lee, J.C.K. A region of homozygous deletion on chromosome 9p. 1-22 in primary nasopharyngeal carcinoma. Cancer Res. 54: 4003-4006, 1994.
33. Nawroz, H. van der Riet, P. Hrubran, R.H. Koch, W. and Sidransky, D. Allelorype of head and neck squamous cell carcinoma. Cancer Res. 54: 1152-1155, 1994.
34. Merlo, A. Gabrielson, E. Askin, F. Baylin, S. and Sidransky, D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res. 54: 640-642, 1994.
35. Olopade, O.I. Buchagen, D.L. Malik, K. Sherman, J. Norbori, T. Bader, S. Nau, M.M. Gazdar, A.F. Minna, J.D. and Diaz, M.O. Homozygous loss of interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res. 53: 2410-2415, 1993.
36. Mead, L.J. Gillespie, M.T. Irving, L.B. and Campbell, L.J. Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer. Cancer Res. 54: 2307-2309, 1994.
37. Boynton, R.F. Huang, Y. Blount, P.L. Reid, B.J. Raskind, W.H. Haggitt, R.C. Newkirk, C. Resau, J.H. Yin, J. McDaniel, T. and Meltzer, S.J. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res. 51: 5766-5769, 1991.
38. Rhyu, M.G. Park, W.S. and Meltzer, S.J. Allelic deletions of APC/MCC and p. 3 are frequent late events in human gastric carcinogenesis. Gastroenterology, 106: 1584-1588, 1994.
39. Kamb, A. Gruis, N.A. Weaver-Feldhaus, J. Liu, Q. Harshman, K. Tavtigian, S.V. Stockert, E. Day, R.S. III, Johnson, B.E. and Skolnick, M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
40. Cairns, P. Mao, L. Merlo, A. Lee, D.J. Schwab, D. Eby, Y. Tokino, K. van der Riet, P. Blaugrund, J.E. and Sidransky, D. Rates of p. 6 (MTS1) mutations in primary tumors with 9p loss. Science (Washington DC), 265: 415-417, 1994.
41. Spruck, CH, III, Gonzalez-Zulueta, M. Shibata, A. Simoneau, A.R. Lin, M.F. Gonzales, F. Tsai, Y.C. and Jones, P.A. p. 6 gene in uncultured tumors. Nature (Lond.), 370: 183-184, 1994.
42. Mori, T. Miura, K. Aoki, T. Nishihira, T. Mori, S. and Nakamura, Y. Frequent somatic mutation of the MTS1/CDK41 (multiple rumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54: 3396-3397, 1994.
43. Huang, Y. Meltzer, S.J. Yin, J. Tong, Y. Chang, E.H. Srivastava, S. McDaniel, T. Boynton, R.F. and Zou, Z.Q. Altered messenger RNA and unique mutational profiles of p. 3 and Rb in human esophageal carcinomas. Cancer Res. 53: 1889-1894, 1993.
44. Hollstein, M.C. Peri, L. Mandard, A.M. Welsh, J.A. Montesano, R. Metcalf, R.A. Bak, M. and Harris, C.C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p. 3 base substitution and absence of ras mutations. Cancer Res. 57: 4102-4106, 1991.
45. Hollstein, M.C. Metcalf, R.A. Welsh, J.A. Montesano, R. and Harris, C.C. Frequent mutation of the p. 3 gene in human esophageal cancer. Cancer Res. 51: 4495-4499, 1991.
46. Casson, A.G. Mukhopadhyay, T. Cleary, K.R. Ro, J.Y. Levin, B. and Roth, J.A. p. 3 gene mutations in Barrett's epithelium and esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958-9961, 1990.
47. Zhou, X. Tannin, L. Yin, J. Jiang, H.Y. Suzuki, H. Rhyu, M.G. Abraham, J.M. and Meltzer, S.J. The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, in press.